Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: review of the general methodology

For the Paediatric Rheumatology International Trials Organisation (PRINTO)

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

The aim of this project was to cross-culturally adapt and validate the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) questionnaire in 54 languages across 52 different countries that are members of the Paediatric Rheumatology International Trials Organisation (PRINTO). This effort was part of a wider project named Epidemiology and Outcome of Children with Arthritis (EPOCA) to obtain information on the frequency of juvenile idiopathic arthritis (JIA) categories in different geographic areas, the therapeutic approaches adopted, and the disease status of children with JIA currently followed worldwide. A total of 13,843 subjects were enrolled from the 49 countries that took part both in the cross-cultural adaptation phase and in the related validation and data collection: Algeria, Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czech Republic, Denmark, Ecuador, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, India, Islamic Republic of Iran, Israel, Italy, Latvia, Libya, Lithuania, Mexico, Netherlands, Norway, Oman, Paraguay, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Serbia, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, Ukraine, United Kingdom and United States of America. 9021 patients had JIA (10.7% systemic arthritis, 41.9% oligoarthritis, 23.5% RF negative polyarthritis, 4.2% RF positive polyarthritis, 3.4% psoriatic arthritis, 10.6% enthesitis-related arthritis and 5.7% undifferentiated arthritis) while 4822 were healthy children. This introductory paper describes the overall methodology; results pertaining to each country are fully described in the accompanying manuscripts. In conclusion, the JAMAR translations were found to have satisfactory psychometric properties and it is thus a reliable and valid tool for the multidimensional assessment of children with JIA.

Original languageEnglish
Pages (from-to)5-17
Number of pages13
JournalRheumatology International
Volume38
DOIs
Publication statusPublished - Apr 1 2018

Fingerprint

Juvenile Arthritis
Psychometrics
Arthritis
Language
Libya
Paraguay
Latvia
Oman
Estonia
Lithuania
Algeria
Ecuador
Slovenia
Serbia
Ukraine
Bulgaria
Romania
Slovakia
Psoriatic Arthritis
Croatia

Keywords

  • Cross-cultural adaptation and psychometric evaluation methodology
  • Healthy children
  • Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
  • Juvenile idiopathic arthritis (JIA)
  • Review

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries : review of the general methodology. / For the Paediatric Rheumatology International Trials Organisation (PRINTO).

In: Rheumatology International, Vol. 38, 01.04.2018, p. 5-17.

Research output: Contribution to journalArticle

@article{a2749f3753704cd5bfce5022038719f7,
title = "Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: review of the general methodology",
abstract = "The aim of this project was to cross-culturally adapt and validate the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) questionnaire in 54 languages across 52 different countries that are members of the Paediatric Rheumatology International Trials Organisation (PRINTO). This effort was part of a wider project named Epidemiology and Outcome of Children with Arthritis (EPOCA) to obtain information on the frequency of juvenile idiopathic arthritis (JIA) categories in different geographic areas, the therapeutic approaches adopted, and the disease status of children with JIA currently followed worldwide. A total of 13,843 subjects were enrolled from the 49 countries that took part both in the cross-cultural adaptation phase and in the related validation and data collection: Algeria, Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czech Republic, Denmark, Ecuador, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, India, Islamic Republic of Iran, Israel, Italy, Latvia, Libya, Lithuania, Mexico, Netherlands, Norway, Oman, Paraguay, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Serbia, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, Ukraine, United Kingdom and United States of America. 9021 patients had JIA (10.7{\%} systemic arthritis, 41.9{\%} oligoarthritis, 23.5{\%} RF negative polyarthritis, 4.2{\%} RF positive polyarthritis, 3.4{\%} psoriatic arthritis, 10.6{\%} enthesitis-related arthritis and 5.7{\%} undifferentiated arthritis) while 4822 were healthy children. This introductory paper describes the overall methodology; results pertaining to each country are fully described in the accompanying manuscripts. In conclusion, the JAMAR translations were found to have satisfactory psychometric properties and it is thus a reliable and valid tool for the multidimensional assessment of children with JIA.",
keywords = "Cross-cultural adaptation and psychometric evaluation methodology, Healthy children, Juvenile Arthritis Multidimensional Assessment Report (JAMAR), Juvenile idiopathic arthritis (JIA), Review",
author = "{For the Paediatric Rheumatology International Trials Organisation (PRINTO)} and Francesca Bovis and Alessandro Consolaro and Angela Pistorio and Marco Garrone and Silvia Scala and Elisa Patrone and Mariangela Rinaldi and Luca Villa and Alberto Martini and Angelo Ravelli and Nicolino Ruperto",
year = "2018",
month = "4",
day = "1",
doi = "10.1007/s00296-018-3944-1",
language = "English",
volume = "38",
pages = "5--17",
journal = "Rheumatology International",
issn = "0172-8172",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries

T2 - review of the general methodology

AU - For the Paediatric Rheumatology International Trials Organisation (PRINTO)

AU - Bovis, Francesca

AU - Consolaro, Alessandro

AU - Pistorio, Angela

AU - Garrone, Marco

AU - Scala, Silvia

AU - Patrone, Elisa

AU - Rinaldi, Mariangela

AU - Villa, Luca

AU - Martini, Alberto

AU - Ravelli, Angelo

AU - Ruperto, Nicolino

PY - 2018/4/1

Y1 - 2018/4/1

N2 - The aim of this project was to cross-culturally adapt and validate the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) questionnaire in 54 languages across 52 different countries that are members of the Paediatric Rheumatology International Trials Organisation (PRINTO). This effort was part of a wider project named Epidemiology and Outcome of Children with Arthritis (EPOCA) to obtain information on the frequency of juvenile idiopathic arthritis (JIA) categories in different geographic areas, the therapeutic approaches adopted, and the disease status of children with JIA currently followed worldwide. A total of 13,843 subjects were enrolled from the 49 countries that took part both in the cross-cultural adaptation phase and in the related validation and data collection: Algeria, Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czech Republic, Denmark, Ecuador, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, India, Islamic Republic of Iran, Israel, Italy, Latvia, Libya, Lithuania, Mexico, Netherlands, Norway, Oman, Paraguay, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Serbia, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, Ukraine, United Kingdom and United States of America. 9021 patients had JIA (10.7% systemic arthritis, 41.9% oligoarthritis, 23.5% RF negative polyarthritis, 4.2% RF positive polyarthritis, 3.4% psoriatic arthritis, 10.6% enthesitis-related arthritis and 5.7% undifferentiated arthritis) while 4822 were healthy children. This introductory paper describes the overall methodology; results pertaining to each country are fully described in the accompanying manuscripts. In conclusion, the JAMAR translations were found to have satisfactory psychometric properties and it is thus a reliable and valid tool for the multidimensional assessment of children with JIA.

AB - The aim of this project was to cross-culturally adapt and validate the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) questionnaire in 54 languages across 52 different countries that are members of the Paediatric Rheumatology International Trials Organisation (PRINTO). This effort was part of a wider project named Epidemiology and Outcome of Children with Arthritis (EPOCA) to obtain information on the frequency of juvenile idiopathic arthritis (JIA) categories in different geographic areas, the therapeutic approaches adopted, and the disease status of children with JIA currently followed worldwide. A total of 13,843 subjects were enrolled from the 49 countries that took part both in the cross-cultural adaptation phase and in the related validation and data collection: Algeria, Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czech Republic, Denmark, Ecuador, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, India, Islamic Republic of Iran, Israel, Italy, Latvia, Libya, Lithuania, Mexico, Netherlands, Norway, Oman, Paraguay, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Serbia, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, Ukraine, United Kingdom and United States of America. 9021 patients had JIA (10.7% systemic arthritis, 41.9% oligoarthritis, 23.5% RF negative polyarthritis, 4.2% RF positive polyarthritis, 3.4% psoriatic arthritis, 10.6% enthesitis-related arthritis and 5.7% undifferentiated arthritis) while 4822 were healthy children. This introductory paper describes the overall methodology; results pertaining to each country are fully described in the accompanying manuscripts. In conclusion, the JAMAR translations were found to have satisfactory psychometric properties and it is thus a reliable and valid tool for the multidimensional assessment of children with JIA.

KW - Cross-cultural adaptation and psychometric evaluation methodology

KW - Healthy children

KW - Juvenile Arthritis Multidimensional Assessment Report (JAMAR)

KW - Juvenile idiopathic arthritis (JIA)

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=85045262642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045262642&partnerID=8YFLogxK

U2 - 10.1007/s00296-018-3944-1

DO - 10.1007/s00296-018-3944-1

M3 - Article

C2 - 29637323

AN - SCOPUS:85045262642

VL - 38

SP - 5

EP - 17

JO - Rheumatology International

JF - Rheumatology International

SN - 0172-8172

ER -